UniPharma Company Description

UniPharma Co., Ltd. engages in the distribution of pharmaceutical drugs, medical devices, and diagnostic tests in Taiwan.

It provides diagnostic tests in areas of oncology, gynecology, orthopedics, neurology, anesthesiology, and cardiology.

The company offers Adept reduction solution; bain, esmolol HCI, and naloxone anesthesia injections; Elisa DR-70 test for in-vitro diagnostics of tumors; and fomeject antidote injection, as well as drug development, research and development, clinical trials, marketing, and other business services.

It serves medical centers, regional and area hospitals, and clinics. UniPharma Co., Ltd. was founded in 1998 and is based in Taipei, Taiwan.

UniPharma Co., Ltd.

Country	Taiwan
Founded	1998
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	31
CEO	Yu-Shan Wang

Contact Details

Address: No.17, Lane 171 Taipei, 11494 Taiwan
Phone	886 2 2658 2577
Website	uni-pharma.com

Stock Details

Ticker Symbol	6621
Exchange	Taipei Exchange
Fiscal Year	January - December
Reporting Currency	TWD
ISIN Number	TW0006621006
SIC Code	5047

Key Executives

Name	Position
Jen Chen Ph.D.	Chairman of the Board and Chief Strategy Officer
Yu-Shan Wang Ph.D.	General Manager, Research & Development Director and Director